Display options
Cite
Prabhakar B, Banu A, Pavithra HB, et al. Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy. Indian J Sex Transm Dis AIDS. 2011;32(2):94-8doi: 10.4103/0253-7184.85412.
Prabhakar, B., Banu, A., Pavithra, H. B., Chandrashekhara, P., & Sasthri, S. (2011). Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy. Indian journal of sexually transmitted diseases and AIDS, 32(2), 94-8. https://doi.org/10.4103/0253-7184.85412
Prabhakar, B, et al. "Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy." Indian journal of sexually transmitted diseases and AIDS vol. 32,2 (2011): 94-8. doi: https://doi.org/10.4103/0253-7184.85412
Prabhakar B, Banu A, Pavithra HB, Chandrashekhara P, Sasthri S. Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy. Indian J Sex Transm Dis AIDS. 2011 Jul;32(2):94-8. doi: 10.4103/0253-7184.85412. PMID: 22021970; PMCID: PMC3195189.
Copy Download .nbib Format: NLM
Share it on

Indian J Sex Transm Dis AIDS. 2011 Jul;32(2):94-8. doi: 10.4103/0253-7184.85412.

Immunological failure despite virological suppression in HIV seropositive individuals on antiretroviral therapy.

Indian journal of sexually transmitted diseases and AIDS

B Prabhakar, Asima Banu, H B Pavithra, P Chandrashekhara, Suresh Sasthri

Affiliations

  1. Department of Medicine, Bowring and Lady Curzon Hospital, Bangalore Medical College and Research Institute, Karnataka, India.

PMID: 22021970 PMCID: PMC3195189 DOI: 10.4103/0253-7184.85412

Abstract

BACKGROUND: Some individuals experience a discordant response during antiretroviral therapy (ART), with a blunted CD4+ cell count response despite low HIV-1 RNA plasma levels.

MATERIALS AND METHODS: CD4 counts and viral load of 251 individuals on ART referred to the center were analysed for immunological failure. The viral load tests of 28 patients revealed a discordant response, characterized by low CD4 counts despite viral suppression (<47 copies in 23, <5000 in 4 patients and <10000 in one patient). Univariate and multiple regression analysis was done to determine factors associated with immunological failure in patients with viral suppression.

RESULTS: Twenty-eight patients developed immunological failure over a duration of 3.7±1.14 years despite viral suppression. In univariate analysis of discordant patients, low CD4 counts(<100cells/μl) at start of ART(P=0.0261), less than 50% gain in CD4 count (P=0.048) after one year of start of ART and duration on ART for more than 3 years (P=0.0436) were associated with immunological failure. In multiple regression, duration on ART, age and nadir CD4 count (lowest ever) on treatment were predictors of immunological failure in these patients. Overall females (n=8) demonstrated much higher CD4 counts of 136±72 than males (n=20) 79±38 cells/μl at the time of diagnosis of immunological failure.

CONCLUSIONS: Discordance was observed in 13.59% of patients. Detection of failure to first line therapy based on immunologic criteria, without viral load testing, can result in unnecessary switches to 2(nd) line therapy.

Keywords: Antiretroviral therapy; discordant response; immunological failure; viral load; viral suppression

References

  1. Pediatrics. 2004 Nov;114(5):e604-11 - PubMed
  2. N Engl J Med. 1997 Sep 11;337(11):725-33 - PubMed
  3. Clin Infect Dis. 2005 Aug 1;41(3):361-72 - PubMed
  4. Immunogenetics. 2005 Oct;57(9):628-35 - PubMed
  5. J Acquir Immune Defic Syndr. 2006 Jan 1;41(1):1-5 - PubMed
  6. AIDS Care. 2007 May;19(5):637-45 - PubMed
  7. J Infect Dis. 2004 Jul 15;190(2):271-9 - PubMed
  8. J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):161-7 - PubMed
  9. AIDS. 2002 Sep 27;16(14):1877-85 - PubMed
  10. Ann Intern Med. 1997 Jun 15;126(12):939-45 - PubMed
  11. JAMA. 1998 Mar 25;279(12):930-7 - PubMed
  12. J Infect Dis. 2003 Apr 1;187(7):1027-37 - PubMed
  13. N Engl J Med. 1999 Dec 16;341(25):1865-73 - PubMed
  14. Ann Intern Med. 1997 Jun 15;126(12):946-54 - PubMed
  15. J Infect Dis. 2001 May 1;183(9):1328-35 - PubMed
  16. Clin Infect Dis. 2002 Oct 15;35(8):1005-9 - PubMed
  17. J Exp Med. 2004 Sep 20;200(6):749-59 - PubMed
  18. N Engl J Med. 1997 Sep 11;337(11):734-9 - PubMed
  19. N Engl J Med. 1999 Dec 16;341(25):1874-81 - PubMed
  20. HIV Med. 2009 Aug;10(7):439-46 - PubMed
  21. J Med Virol. 2005 Jun;76(2):153-60 - PubMed
  22. Annu Rev Immunol. 2003;21:265-304 - PubMed
  23. BMC Infect Dis. 2006 Jan 24;6:10 - PubMed
  24. J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):288-93 - PubMed

Publication Types